In Reply to Hannoun-Levi et al
Int J Radiat Oncol Biol Phys
.
2022 Jun 1;113(2):475-477.
doi: 10.1016/j.ijrobp.2022.02.034.
Authors
Asal Rahimi
1
,
Ambrosia Simmons
2
,
D Nathan Kim
2
,
Marilyn Leitch
3
,
Jonathan Haas
4
,
Xuejun Gu
2
,
Chul Ahn
5
,
Ang Gao
5
,
Ann Spangler
2
,
Howard E Morgan
2
,
Sally Goudreau
6
,
Stephen Seiler
6
,
Deborah Farr
3
,
Rachel Wooldridge
3
,
Barbara Haley
7
,
Shohreh Bahrami
2
,
Sarah Neufeld
2
,
Christopher Mendez
4
,
Prasanna Alluri
2
,
Roshni Rao
8
,
Robert D Timmerman
2
Affiliations
1
Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address: Asal.Rahimi@UTSouthwestern.edu.
2
Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.
3
Surgery, University of Texas Southwestern Medical Center, Dallas, Texas.
4
Perlmutter Cancer Center, NYU Langone Hospital, Long Island, New York.
5
Biostatistics, University of Texas Southwestern Medical Center, Dallas, Texas.
6
Radiology, University of Texas Southwestern Medical Center, Dallas, Texas.
7
Medical Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.
8
Breast Surgery, Columbia University Medical Center, New York City, New York.
PMID:
35569485
DOI:
10.1016/j.ijrobp.2022.02.034
No abstract available
Publication types
Letter